{"organizations": [], "uuid": "05e3116800bda163614cc201c806293f1af01eb5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "https://fm.cnbc.com/applications/cnbc.com/resources/img/editorial/2017/12/04/104877513-RTX3KKRV.1910x1000.jpg", "site_section": "https://www.cnbc.com/id/15839135/device/rss/rss.html", "section_title": "Earnings", "url": "https://www.cnbc.com/2018/05/02/cvs-health-profit-rises-4-point-8-percent.html", "country": "US", "domain_rank": 767, "title": "CVS beats on profit as prescription sales surge", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-02T15:28:00.000+03:00", "replies_count": 0, "uuid": "05e3116800bda163614cc201c806293f1af01eb5"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/05/02/cvs-health-profit-rises-4-point-8-percent.html", "ord_in_thread": 0, "title": "CVS beats on profit as prescription sales surge", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "cvs", "sentiment": "negative"}, {"name": "cvs health", "sentiment": "negative"}, {"name": "aetna", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "CVS Health posted a better-than-expected first-quarter profit on Wednesday, helped by higher sales of prescription drugs at its stores, sending its shares up 4.3 percent in trading before the bell.\nThe company also said that it was sticking with its expectations of closing the $69 billion deal to buy Aetna in the second half of the year.\nCVS's total same store sales increased 5.8 percent, while pharmacy same store sales surged 7.3 percent on higher prices of branded drugs and partnerships with other pharmacy benefits managers.\nOverall revenue from the company's retail business increased 5.6 percent to about $20.4 billion.\nHowever, the company's retail business accounts for a shrinking share of its total sales, with most revenue now coming from its pharmacy benefits manager, which serves as a middleman between insurance companies, pharmacies and drugmakers.\nNet revenue from its pharmacy benefit management business rose 3.2 percent to $32.22 billion, driven by higher claims on costlier drugs among other things.\nNet income attributable to the company rose to $998 million, or 98 cents per share, in the reported quarter ended March 31 from $952 million, or 92 cents per share, a year earlier.\nNet revenue rose 2.6 percent to $45.69 billion.\nExcluding items, it earned $1.48 per share, beating analysts' estimates of $1.41, according to Thomson Reuters I/B/E/S.", "external_links": [], "published": "2018-05-02T15:28:00.000+03:00", "crawled": "2018-05-02T15:18:20.006+03:00", "highlightTitle": ""}